α-Amylase-IN-13

Overview

α-Amylase-IN-13 is an orally active, selective, brain-penetrant α-amylase inhibitor ( IC 50 = 0.71 μM). α-Amylase-IN-13 inhibits α-amylase through a mixed type of inhibition mechanism. α-Amylase-IN-13 leads to a significant reduction in blood glucose level in diabetic rats. α-Amylase-IN-13 causes significant histopathological improvements in the kidney, liver, and pancreas. α-Amylase-IN-13 can be used for the study of diabetic complications.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Research Areas > Endocrinology | Products > Signaling Pathways > Amylases

Product Information

• Catalog No.: HY-178363
• CAS No.: 3085413-64-2
• Molecular Formula: C17H13F3N4O2S2
• Molecular Weight: 426.44
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source